%20(2).png)
Contact
Phone
+44 (0)207 305 5815
+44 (0)7914 414363
Location
124 City Road
London
EC1V 2NX
United Kingdom
Black Cat Bio Limited welcomes inquiries from global animal health companies, research collaborators, and strategic partners interested in the CS20 bivalent PRRSV vaccine platform.
Whether you are exploring licensing opportunities, regulatory collaboration, or scientific due diligence, our team is available to provide further information and discuss potential partnership structures.
We are actively engaging with selected partners to advance CS20 toward global regulatory pathways and commercialization. We welcome serious inquiries from established organizations in the animal health sector.
Building the Next Generation of PRRSV Solutions
The global swine industry continues to face evolving challenges from PRRSV, requiring more adaptive, scientifically advanced, and commercially scalable vaccine strategies. Our work is focused on closing that gap through innovation, collaboration, and rigorous scientific validation.
Black Cat Bio Limited is committed to advancing CS20 through its final stages of development and into strategic global partnerships that can bring meaningful impact to animal health systems worldwide.
We welcome collaboration with organizations that share a long-term vision for improving disease control, production efficiency, and sustainability in global livestock farming.